LIQUI SRS Trademark
LIQUI SRS is a USPTO trademark filed by EMOVIAR PharmaCon GmbH. Status: Registered.
Trademark Facts
| Mark | LIQUI SRS |
|---|---|
| Serial Number | 98256227 |
| Registration Number | 8146142 |
| Status | Registered |
| Filing Date | 2023-11-06 |
| Registration Date | 2026-02-17 |
| Mark Type | Word |
| Nice Classes | 042 (Software & IT) |
| Owner | EMOVIAR PharmaCon GmbH |
| Attorney of Record | Elizabeth M. O'Donoghue |
| Prosecution Events | 34 |
| Latest Event | R.PR on 2026-02-17 |
Goods & Services
Pharmaceutical drugs for the treatment and prevention of chronic and non-chronic diseases, namely, pain diseases, cardiovascular diseases, cancer diseases, infectious diseases, neural diseases, respiratory diseases, obesity diseases, and kidney diseases; Drug delivery agents in particular sustained release agents in the form of capsules and tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drugs for medical for purposes in particular sustained release drug formulations for the treatment and prevention of chronic and non-chronic diseases, namely, pain diseases, cardiovascular diseases, cancer diseases, infectious diseases, neural diseases, respiratory diseases, obesity diseases, and kidney diseases; Drug discovery services; biological research; clinical research in the medical, pharmaceutical, and biotechnology fields; medical research; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields for the pharmaceutical industry; pharmaceutical products development; pharmaceutical formulation in the nature of pharmaceutical products development; biomedical research services; medical and scientific research in the field of pharmacogenetics; research and development of vaccines and medicines; pharmaceutical drug development services; development of pharmaceutical preparations in particular sustained release formulations and medicines; pharmaceutical research services.